Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: J Immunol. 2016 Feb 10;196(6):2809–2818. doi: 10.4049/jimmunol.1500156

Table I.

SIVΔnef RNA in mucosal sites and lymphoid tissues1

Days post
vaccination
Number of SIV RNA copies 108 CE
4 7 11 14
Pelvic LN NA 4.7×107 NA NA
Inguinal LN 5.8×105 7×106 NA 3.6×106
Mesenteric LN 2.3×105 NA 2×106 2.9×106
Axillary LN 4.7×104 2×106 3×105 3.5×105
GALT 1.1×106 1.7×106 1.1×105 1.9×106
Spleen 2.5×106 4.9×107 5.6×106 2.3×107
Lung 4×103 2×104 1.8×104 5.6×104
Cervix 7.7 × 102 1.5 ×106 9.3×103 7.4×105
Vagina 1.8×102 2.7×105 1.9×104 1.4×104
Weeks post vaccination 5 5 5
Cervix 4×103 6.8×103 2.4×103
Vagina NA NA 7.9×104
20 20 20
Cervix 6.4×102 1.3×102 7.9×102
Vagina NA NA 5.8×104
1

SIV RNA copies per 108 cell equivalents (CE). When sufficient tissue was available for the assay, RNA was extracted from single animals from the tissue sites and days shown following SIVΔnef iv infection. There was sufficient cervical and vaginal tissue available from 3 animals each at 5 and 20 weeks for the assay. Copy numbers in extracted tissue RNA were determined by RT-PCR using specific primers, and expressed as number of copies of SIVΔnef RNA per 108 CE. The values shown for GALT are the highest respectively for jejunum, ileum, colon and rectum. NA, tissue samples of sufficient size for the assay were not available.